Hierarchy: 23andMe, Regeneron Pharmaceuticals, Inc.

23andMe and Regeneron Pharmaceuticals, Inc. have/had a hierarchical relationship

Start Date 2025-05-00
Notes Pending approval by bankruptcy court at a purchase price of $256 million.
Updated 3 months ago

Source Links